![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, August 06, 2015 12:02:45 PM
Dear someconcerns,
We wanted to let you know that we’ve deleted the post copied at the end of this email, and to explain why. It was deleted because it contains an allegation of bad faith against another user. We welcome (or even encourage!) disagreement with the perspectives offered by others on the site. We ask, however, that you provide evidence to support your arguments for how and why you disagree, rather than impugning the author’s motivation. Allegations of impropriety should be brought up privately with a member of the editorial staff, or the disputes team. If you believe that there are serious problems with an article we encourage you to file a formal dispute here: http://seekingalpha.com/page/dispute_an_article. If this relates to undisclosed payments, please send evidence to integrity@seekingalpha.com. The comments section is not the appropriate place to air such allegations. Public arguments about intent inflame passions and seldom lead to civil, or useful, discussion.
Please understand that we do strive to err on the side of facilitating free and open debate. This means that we are never happy about having to remove a comment. That said, in order to ensure that Seeking Alpha continues to be the go-to destination for serious investment discussion, comments must adhere to our guidelines, which can be found here: http://seekingalpha.com/page/comment_guidelines?source=moddeletion
Respectfully,
Seeking Alpha Moderation Team
-----------------
User Data:
Posted by: someconcerns, userID: 618063, email: xxx@xxx
user since: April 6, 2010
Dates previously in moderation:
Apr 6, 2010 - May 26, 2013
Content Data:
Content submitted on August 6, 2015, 11:01
On Article Cellceutix: Empty Office, Unviable 'Science', Misleading Disclosures, 96% Downside by Mako Research
Original comment:
Thank you for at least acknowledging that you are short the stock. Probably the only thing true here. You must really be desperate to drop the share price.
Content link: http://seekingalpha.com/article/3406365-cellceutix-empty-office-unviable-science-misleading-disclosures-96-percent-downside#comment-57925576
All I say is IMHO and not to be construed as investment advice. I know nothing, as informed frequently by my wife.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM